Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.

[1]  S. Hunt,et al.  A single non‐invasive model to diagnose non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) , 2014, Journal of gastroenterology and hepatology.

[2]  Henry Völzke,et al.  Development, External Validation, and Comparative Assessment of a New Diagnostic Score for Hepatic Steatosis , 2014, The American Journal of Gastroenterology.

[3]  Shih-Jen Hwang,et al.  Renal artery calcium, cardiovascular risk factors, and indexes of renal function. , 2014, The American journal of cardiology.

[4]  Shi Fuyan,et al.  Fatty Liver Disease Index: A Simple Screening Tool to Facilitate Diagnosis of Nonalcoholic Fatty Liver Disease in the Chinese Population , 2013, Digestive Diseases and Sciences.

[5]  Eliseo Guallar,et al.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. , 2013, American journal of epidemiology.

[6]  K. Kohara,et al.  Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults , 2012, Cardiovascular Diabetology.

[7]  Dong Li,et al.  Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. , 2012, Academic radiology.

[8]  K. Cusi,et al.  Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[9]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[10]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[11]  Tae Hyeon Kim,et al.  Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease , 2011, The Korean journal of hepatology.

[12]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[13]  H. Kim,et al.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[14]  Udo Hoffmann,et al.  Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study , 2010, Hepatology.

[15]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[16]  J. Hirschhorn,et al.  Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study , 2008, Journal of gastroenterology and hepatology.

[17]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[18]  B. Son,et al.  The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. , 2006, Metabolism: clinical and experimental.

[19]  Anna Castiglione,et al.  The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.

[20]  Michaela Diamant,et al.  Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease , 2006, Diabetes/metabolism research and reviews.

[21]  Sang Won Lee,et al.  Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.

[22]  Deniz Güney Duman,et al.  Computed Tomography in Nonalcoholic Fatty Liver Disease , 2006, Digestive Diseases and Sciences.

[23]  E. Boyko,et al.  The Prevalence and Predictors of Elevated Serum Aminotransferase Activity in the United States in 1999–2002 , 2006, The American Journal of Gastroenterology.

[24]  A. Lazenby,et al.  Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women , 2005, Hepatology.

[25]  N. Weiss,et al.  Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. , 2005, Gastroenterology.

[26]  E. Yano,et al.  Efficacy and Effectiveness of Liver Screening Program to Detect Fatty Liver in the Periodic Health Check‐Ups , 2004, Journal of occupational health.

[27]  A. Häkkinen,et al.  Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk , 2004, Diabetologia.

[28]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[29]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[30]  C. Ryan,et al.  One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[32]  E. Gunter,et al.  Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 , 1996 .

[33]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[34]  A. Nanji,et al.  Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients. , 1986, Enzyme.